Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KINDRED BIOSCIENCES, INC.

(KIN)
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from S&P TMI Index

08/30/2021 | 12:00am EST

Kindred Biosciences, Inc.(NasdaqCM:KIN) dropped from S&P TMI Index


ę S&P Capital IQ 2021
All news about KINDRED BIOSCIENCES, INC.
2021Vaxart, Inc. acquired KindredBio's manufacturing equipment and GMP manufacturing facili..
CI
2021KINDRED BIOSCIENCES : Market Offering Agreement (Form 8-K)
PU
2021KINDRED BIOSCIENCES, INC. : Termination of a Material Definitive Agreement, Completion of ..
AQ
2021Kindred Biosciences, Inc. Announces Board Changes
CI
2021ELANCO ANIMAL HEALTH INCORPORATED : Closes Purchase of Kindred Biosciences for About $444 ..
MT
2021KINDRED BIOSCIENCES, INC.(NASDAQCM : KIN) dropped from S&P Global BMI Index
CI
2021KINDRED BIOSCIENCES, INC.(NASDAQCM : KIN) dropped from S&P TMI Index
CI
2021KINDRED BIOSCIENCES, INC.(NASDAQGM : KIN) dropped from NASDAQ Composite Index
CI
2021Elanco Animal Health Incorporated completed the acquisition of Kindred Biosciences, Inc..
CI
2021KINDRED BIOSCIENCES, INC. : Submission of Matters to a Vote of Security Holders, Financial..
AQ
More news
Analyst Recommendations on KINDRED BIOSCIENCES, INC.
More recommendations
Financials (USD)
Sales 2020 3,46 M - -
Net income 2020 -21,8 M - -
Net cash 2020 35,0 M - -
P/E ratio 2020 -7,77x
Yield 2020 -
Capitalization 421 M 421 M -
EV / Sales 2019 66,3x
EV / Sales 2020 39,0x
Nbr of Employees 63
Free-Float 81,0%
Chart KINDRED BIOSCIENCES, INC.
Duration : Period :
Kindred Biosciences, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Hangjun Zhan Chief Scientific Officer
Katja Buhrer COO & VP-Corporate Development & Investor Relation
David Pugh Director
Kathleen St. Louis Director
Jinee Majors Director
Sector and Competitors
1st jan.Capi. (M$)
KINDRED BIOSCIENCES, INC.114.62%421
GILEAD SCIENCES, INC.-4.88%86 640
REGENERON PHARMACEUTICALS-2.12%64 627
VERTEX PHARMACEUTICALS5.12%58 692
WUXI APPTEC CO., LTD.-6.39%51 406
BIONTECH SE-37.29%39 044